Paul Tempest

Person

Taipei City, TW

People

Patents Grantslast 30 patents

Information Patent Grant
Aryl and heteroaryl ether derivatives as liver X receptor beta agon...
- Patent number 11,655,216
- Issue date May 23, 2023
- Merck Sharp & Dohme LLC
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for degrading Tau protein aggregates and uses thereof
- Patent number 11,642,413
- Issue date May 9, 2023
- APRINOIA THERAPEUTICS LIMITED
- Paul Tempest
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for degrading α-synuclein aggregates and uses thereof
- Patent number 11,291,732
- Issue date Apr 5, 2022
- APRINOIA THERAPEUTICS LIMITED
- Ming-Kuei Jang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-aryl and N-heteroaryl piperidine derivatives as liver X receptor...
- Patent number 10,961,215
- Issue date Mar 30, 2021
- Merck Sharp & Dohme Corp.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine derivatives as liver X receptor beta agonists, compositi...
- Patent number 10,894,775
- Issue date Jan 19, 2021
- Merck Sharp & Dohme Corp.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted aminoquinazoline compounds as A2A antagonist
- Patent number 10,822,338
- Issue date Nov 3, 2020
- Merck Sharp & Dohme Corp.
- Amjad Ali
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES THEREOF
- Publication number 20230346955
- Publication date Nov 2, 2023
- Aprinoia Therapeutics Limited
- Paul TEMPEST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES THEREOF
- Publication number 20220354835
- Publication date Nov 10, 2022
- Aprinoia Therapeutics Limited
- Ming-Kuei JANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR DEGRADING ALPHA-SYNUCLEIN AGGREGATES AND USES THEREOF
- Publication number 20220280650
- Publication date Sep 8, 2022
- Aprinoia Therapeutics Limited
- Ming-Kuei JANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES THEREOF
- Publication number 20220267316
- Publication date Aug 25, 2022
- Aprinoia Therapeutics Limited
- Paul TEMPEST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGON...
- Publication number 20200247754
- Publication date Aug 6, 2020
- MERCK SHARP & DOHME CORP.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-ARYL AND N-HETEROARYL PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR...
- Publication number 20200039951
- Publication date Feb 6, 2020
- MERCK SHARP & DOHME CORP.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITI...
- Publication number 20190375716
- Publication date Dec 12, 2019
- MERCK SHARP & DOHME CORP.
- Michael T. Rudd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST
- Publication number 20180362530
- Publication date Dec 20, 2018
- MERCK SHARP & DOHME CORP.
- Amjad Ali
- C07 - ORGANIC CHEMISTRY

Paul Tempest

Person

Patents Grantslast 30 patents

Aryl and heteroaryl ether derivatives as liver X receptor beta agon...

Compounds for degrading Tau protein aggregates and uses thereof

Compounds for degrading α-synuclein aggregates and uses thereof

N-aryl and N-heteroaryl piperidine derivatives as liver X receptor...

Piperidine derivatives as liver X receptor beta agonists, compositi...

Substituted aminoquinazoline compounds as A2A antagonist

Patents Applicationslast 30 patents

COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES THEREOF

COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES THEREOF

COMPOUNDS FOR DEGRADING ALPHA-SYNUCLEIN AGGREGATES AND USES THEREOF

COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES THEREOF

ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGON...

N-ARYL AND N-HETEROARYL PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR...

PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITI...

SUBSTITUTED AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST